Article
STING pathway agonism as a cancer therapeutic
1 Jul 2019
Abstract excerpt
Abstract The fact that a subset of human cancers showed evidence for a spontaneous adaptive immune response as reflected by the T cell‐inflamed tumor microenvironment phenotype led to the search for candidate innate immune pathways that might be driving such endogenous responses. Preclinical studies indicated a major role for the host STING pathway, a cytosolic DNA sensing pathway, as a proximal event required...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
